Author:
Seet Wan Tai,Mat Afandi Mohd Asyraf,Shamsuddin Sharen Aini,Lokanathan Yogeswaran,Ng Min Hwei,Maarof Manira
Reference74 articles.
1. Abou-El-Enein M, Römhild A, Kaiser D, Beier C, Bauer G, Volk H-D, Reinke P (2013) Good manufacturing practices (GMP) manufacturing of advanced therapy medicinal products: a novel tailored model for optimizing performance and estimating costs. Cytotherapy 15:362–383
2. Amariglio N, Hirshberg A, Scheithauer BW, Cohen Y, Loewenthal R, Trakhtenbrot L, Paz N, Koren-Michowitz M, Waldman D, Leider-Trejo L, Toren A, Constantini S, Rechavi G (2009) Donor-derived brain tumor following neural stem cell transplantation in an ataxia telangiectasia patient. PLoS Med 6:e1000029
3. AQM (2021) Document control explained, American Quality Management. https://aqmauditing.com/iso-9001-consulting/document-control/. Accessed 23 Apr 2021
4. ASQ (2020) Quality assurance & quality control. https://asq.org/quality-resources/quality-assurance-vs-control. Accessed 19 Mar 2021
5. Bedford P, Jy J, Collins L, Keizer S (2018) Considering cell therapy product “good manufacturing practice” status. Front Med (Lausanne) 5:118
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献